Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Click here to sign in with or

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
02/02/2022

Archive: 02/02/2022

European Society of Human Reproduction and Embryology updates guideline on endometriosis care

A new guideline on the diagnosis, treatment and management of endometriosis has been published today by the European Society of Human Reproduction and Embryology (ESHRE).

Feb 2, 2022

0

2

Why taking fever-reducing meds and drinking fluids may not be the best way to treat flu and fever

As flu season progresses, so does the chorus of advice, professional and otherwise, to drink plenty of fluids and take fever-reducing medications, like acetaminophen, ibuprofen or aspirin.

Feb 2, 2022

0

28

Lowering homocysteine with vitamin supplements to treat drug-resistant hypertension

Using B vitamins to lower homocysteine levels is an effective means of reducing blood pressure and may be especially useful in the management of drug-resistant hypertension, according to researchers at the University of Maine ...

Feb 2, 2022

0

11

Sex differences in brain cell development offer clues into disease risk

A new Yale study reveals that astrocytes, a type of glial cell found in the central nervous system, develop at different rates in male and female mice, differences that could affect how neural networks are constructed and ...

Feb 2, 2022

0

70

Diet decisions can make teens feel good about themselves

Key healthy food messages are giving Australian adolescents clear boundaries to set core beliefs and moral decisions about ethical eating choices and junk food risks—which even paves the way for raising their sense of self-worth, ...

Feb 2, 2022

0

0

My child has croup. Could it be COVID? What do I need to know?

With the surge in omicron cases, doctors are finding presentations of croup in children seeking hospital care for COVID in Australia and internationally.

Feb 2, 2022

0

24

The baffling case of metabolically healthy obese people: Are they protected from chronic diseases?

There is a growing global body positivity movement to combat the stigma and prejudice that overweight and obese individuals face. Some of this stigma arises from the perception that obese individuals are unhealthy.

Feb 2, 2022

0

18

The most challenging phase of the omicron outbreak is yet to come, but NZ may be better prepared than most

Within a month of the first community exposure to omicron in Aotearoa New Zealand, the variant has already become the dominant strain of COVID-19.

Feb 2, 2022

0

10

Drug that targets macrophages offers new hope to select patients with ALS

A new drug has been found to slow or temporarily stall the progression of ALS (amyotrophic lateral sclerosis) in a select group of patients. The drug, a proprietary form of purified chlorite that inhibits production of pro-inflammatory ...

Feb 2, 2022

1

25

Neural stem cell therapy may improve metastatic cancer survival

Neural stem cells (NSCs) engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2-positive breast cancer brain metastases, according ...

Feb 2, 2022

0

97

page 8 from 9

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2024 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us